{
  "schema_version": "5.0",
  "artifact_kind": "company_profile",
  "language": "zh-CN",
  "generated_on": "2026-11-11",
  "research_as_of": "2026-11-10",
  "input_context": {
    "name_zh": "金赛药业",
    "name_en": "GenSci",
    "industry_level1": "医药健康",
    "industry_level2": "",
    "official_website": "www.genscigroup.com",
    "company_type": "品牌方",
    "logo_url": "https://img.logo.dev/www.genscigroup.com?token=pk_C1w9wXUfQkaYSJRJ-OQSCQ&size=256&format=webp&fallback=404"
  },
  "entity": {
    "name_zh": "长春金赛药业有限责任公司",
    "scope": "金赛自身及下属经营，不用长春高新整体数据；金派格、营养与数字产品纳入，代理品牌及历史待核业务明确角色/状态。长春高新直接持股99.50%。",
    "source_ids": [
      "S01",
      "S02",
      "S04"
    ]
  },
  "basic_info": [
    {
      "key": "legal_name",
      "label": "法定主体或所属主体",
      "value": "长春金赛药业有限责任公司",
      "source_ids": [
        "S01",
        "S04"
      ]
    },
    {
      "key": "founded",
      "label": "成立时间",
      "value": "1997年（现行官网沿革）；旧官网报道另称1996年创立，确切登记沿革未统一",
      "source_ids": [
        "S04",
        "S36"
      ]
    },
    {
      "key": "headquarters",
      "label": "总部",
      "value": "上海科创总部及研发中心：浦东新区芙蓉花路299号；长春行政/生产总部：朝阳区震宇街海容广场及长春生产园区",
      "source_ids": [
        "S04",
        "S13",
        "S20"
      ]
    },
    {
      "key": "listing",
      "label": "上市情况",
      "value": "金赛自身非独立上市公司；控股股东为长春高新技术产业（集团）股份有限公司（深交所000661），持股99.50%",
      "source_ids": [
        "S01",
        "S02",
        "S04"
      ]
    },
    {
      "key": "employees",
      "label": "员工人数",
      "value": 9000,
      "unit": "人",
      "as_of": "2025-12-23",
      "scope": "原文为“9000余名”，本字段9000为该近似表述的门槛数字，绝非精确统计总数；2025-12-23有发布日期公司新闻自述现有员工，未说明全部下属公司；无日期8000+和近万人不替代。",
      "source_ids": [
        "S34"
      ],
      "display": "9,000人"
    },
    {
      "key": "revenue",
      "label": "营业收入",
      "value": 9819078844.96,
      "unit": "CNY",
      "period": {
        "start": "2025-01-01",
        "end": "2025-12-31",
        "basis": "calendar_year"
      },
      "scope": "2025年长春高新年报主要子公司表及非全资子公司财务信息所列金赛药业营业收入；不是上市集团12083140489.05元",
      "source_ids": [
        "S01"
      ],
      "display": "98.19亿元人民币"
    },
    {
      "key": "current_year_revenue",
      "label": "今年营业收入",
      "value": 6676000000,
      "unit": "CNY",
      "period": {
        "start": "2026-01-01",
        "end": "2026-09-30",
        "basis": "calendar_year"
      },
      "scope": "2026前三季度金赛药业分项实际收入，原报仅披露66.76亿元，换算值保留原约数精度，不伪造元级精度；首披29日晚，签署28日、归档30日",
      "statement_date": "2026-10-29",
      "source_ids": [
        "S03",
        "S37"
      ],
      "display": "66.76亿元人民币"
    },
    {
      "key": "international_revenue",
      "label": "国际业务收入",
      "value": "-",
      "source_ids": [],
      "display": "-"
    },
    {
      "key": "international_revenue_share",
      "label": "国际收入占比",
      "value": "-",
      "source_ids": [],
      "display": "-"
    },
    {
      "key": "sales_coverage",
      "label": "销售覆盖国家及地区",
      "value": "-",
      "source_ids": [],
      "display": "-"
    }
  ],
  "overview": {
    "paragraphs": [
      {
        "text": "金赛是长春高新持股99.50%的制药子公司，上海为科创总部与研发中心，长春为行政/生产总部。产品从生长激素拓展到女性健康、炎症痛风、过敏、肿瘤支持及其他药械；另经营PEG原料与定制、营养食品和家庭数字训练。",
        "source_ids": [
          "S01",
          "S04",
          "S13",
          "S14",
          "S22"
        ]
      },
      {
        "text": "2025金赛分项收入98.1908亿元；2026前三季度累计66.76亿元（原报约数）。金赛2025境外收入及占比未单列，不能采用长春高新的集团国外数据。GenSci098授权7000万美元首款于2026年1月到账、上半年确认，候选药仍在临床阶段。",
        "source_ids": [
          "S01",
          "S02",
          "S03",
          "S28"
        ]
      }
    ]
  },
  "business": {
    "paragraphs": [
      {
        "text": "金赛现行完整目录的交付不止处方药：生长激素、辅助生殖/女性药、IL1β抗炎药、神经药、皮肤创面/局麻药、肿瘤支持与长效激素制剂，以及过敏诊断/治疗、电子注射笔、医美填充材料和能量设备、营养食品与数字训练均分列。赛增、金赛增、金赛恒、金蓓欣等为药品或器械商品名，不把每剂型和适应症拆成公司。",
        "source_ids": [
          "S05",
          "S06",
          "S07",
          "S08",
          "S09",
          "S10",
          "S11",
          "S25",
          "S30",
          "S31"
        ]
      },
      {
        "text": "金派格是金赛全资子公司，除保障内部PEG供应，也实际对外销售PEG及LNP相关原料，提供保密路线设计、合成分析和聚乙二醇化服务。FindCare与金蓓高是营养品牌；Neauvia、ALK产品、美适亚和益普舒保留代理/引进角色，不把外部权利方变成金赛全资品牌或全球制造商。",
        "source_ids": [
          "S12",
          "S13",
          "S14",
          "S15",
          "S16",
          "S17",
          "S18",
          "S19",
          "S21",
          "S23"
        ]
      },
      {
        "text": "金数稳为线上CBIT训练小程序及家庭方案服务，与实物电子注射笔分开；内部GenMOL、GenROS和外部Partex模型合作不构成已确认对外托管API。GenSci098/YB101为已许可临床候选药，许可交付与上市药销售分开；GenSci171/ACARIZAX中国三期达终点仍不是中国上市批准。",
        "source_ids": [
          "S21",
          "S22",
          "S26",
          "S28",
          "S29",
          "S34"
        ]
      },
      {
        "text": "2024年报另列固益素、赛必健、赛优姿、骨龄及生长检测设备、褪黑素贴片、儿童语言训练和金赛克中药等，现行完整目录未全部续列。下列历史条目标明持续销售或服务待核，不断言已停产，也不假定全部持续经营；美国Brillian/Sciecure有受控经营及少量收入披露，但可靠最新产品目录未能取得，不补造具体在售药。",
        "source_ids": [
          "S01",
          "S02",
          "S33"
        ]
      }
    ],
    "brands": [
      {
        "name": "金赛药业 GenSci",
        "description": "统一制药经营品牌，目录同时有自研、合作和独家经销商品；赛增/金赛增等具体商品名保留，外部TWi与逸达等权利方不转为自有。",
        "source_ids": [
          "S01",
          "S04",
          "S05",
          "S21"
        ],
        "website": "https://www.genscigroup.com/",
        "industries": [
          {
            "level1": "医药健康",
            "level2": "药物与药械"
          }
        ],
        "products": [
          {
            "category": "生长激素药品",
            "series": [],
            "representative_products": [
              {
                "name": "赛增",
                "website": null
              },
              {
                "name": "金赛增",
                "website": null
              }
            ],
            "description": "赛增粉针/短效水针与金赛增长效金培生长激素，均为药品；超长效月制剂及口服候选药仍在研究，不混为已上市。",
            "source_ids": [
              "S01",
              "S02",
              "S05"
            ],
            "website": "https://www.genscigroup.com/commercial-products/core-products"
          },
          {
            "category": "生殖、女性激素与儿童性早熟药",
            "series": [],
            "representative_products": [
              {
                "name": "金赛恒",
                "website": null
              },
              {
                "name": "金赛佳",
                "website": null
              },
              {
                "name": "金赛欣",
                "website": null
              },
              {
                "name": "金赛捷",
                "website": null
              },
              {
                "name": "金磊",
                "website": null
              },
              {
                "name": "金赛蓓",
                "website": null
              },
              {
                "name": "注射用醋酸曲普瑞林II",
                "website": null
              }
            ],
            "description": "促卵泡激素粉剂、短效/长效水剂，黄体酮、西曲瑞克、曲普瑞林及替勃龙等；2026新增1月缓释曲普瑞林II治疗限定CPP儿童，区别于短效注射液。",
            "source_ids": [
              "S01",
              "S02",
              "S05",
              "S08",
              "S10",
              "S11",
              "S31"
            ],
            "website": "https://www.genscigroup.com/commercial-products/core-products"
          },
          {
            "category": "痛风及炎症生物药",
            "series": [],
            "representative_products": [
              {
                "name": "金蓓欣",
                "website": null
              }
            ],
            "description": "IL1β单抗伏欣奇拜单抗粉针/水针用于获批急性痛风性关节炎等；其他风湿、眼科或妇科适应症仍按临床进展，不扩成全范围已获批。",
            "source_ids": [
              "S01",
              "S02",
              "S05",
              "S08"
            ],
            "website": "https://www.genscigroup.com/commercial-products/core-products"
          },
          {
            "category": "神经系统药品",
            "series": [],
            "representative_products": [
              {
                "name": "思源清",
                "website": null
              },
              {
                "name": "金斯明",
                "website": null
              }
            ],
            "description": "托莫西汀胶囊与利斯的明透皮贴剂分别面向注意力缺陷多动及阿尔茨海默症状等批准范围；不是数字训练产品。",
            "source_ids": [
              "S06",
              "S08",
              "S22",
              "S23"
            ],
            "website": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/pediatric-neurology"
          },
          {
            "category": "创面修复生物制剂",
            "series": [],
            "representative_products": [
              {
                "name": "金扶宁",
                "website": null
              }
            ],
            "description": "外用人粒细胞巨噬细胞刺激因子凝胶，商品名金扶宁；与口腔医疗器械凝胶和医美注射填充材料分开。",
            "source_ids": [
              "S01",
              "S06",
              "S23"
            ],
            "website": "https://www.genscigroup.com/commercial-products/others-products"
          },
          {
            "category": "皮肤局部麻醉制剂",
            "series": [],
            "representative_products": [
              {
                "name": "金赛宁",
                "website": null
              },
              {
                "name": "金蔓佳",
                "website": null
              },
              {
                "name": "赛达久",
                "website": null
              }
            ],
            "description": "利丙双卡因乳膏，金赛宁、金蔓佳及赛达久为实际商品名，未将同一配方的不同商标当三项独立药物技术。",
            "source_ids": [
              "S01",
              "S06",
              "S23"
            ],
            "website": "https://www.genscigroup.com/commercial-products/others-products"
          },
          {
            "category": "肿瘤厌食恶病质药品",
            "series": [],
            "representative_products": [
              {
                "name": "美适亚",
                "website": null
              }
            ],
            "description": "TWi纳米晶醋酸甲地孕酮口服混悬液美适亚，为金赛新加坡公司取得约定地区独家总经销的引进产品；不是金赛自创全部全球权利。",
            "source_ids": [
              "S01",
              "S02",
              "S05",
              "S21"
            ],
            "website": "https://www.genscigroup.com/commercial-products/core-products"
          },
          {
            "category": "肿瘤支持医疗器械",
            "series": [],
            "representative_products": [
              {
                "name": "益普舒",
                "website": null
              }
            ],
            "description": "益普舒口腔凝胶用于放化疗引起的口腔溃疡覆盖；官方说明书标医疗器械注册证，Solasia为注册人、Rechon为生产商、金赛新加坡为经销商，区别于抗癌药或金赛自产凝胶。",
            "source_ids": [
              "S01",
              "S08",
              "S33",
              "S38"
            ],
            "website": "https://www.genscigroup.com/commercial-products/others-products_3"
          },
          {
            "category": "引进长效抗肿瘤内分泌制剂",
            "series": [],
            "representative_products": [
              {
                "name": "甲磺酸亮丙瑞林注射液6M（逸达合作）",
                "website": null
              }
            ],
            "description": "与逸达合作的甲磺酸亮丙瑞林注射液6M，境外生产药品已获中国前列腺癌注册；国内乳腺癌申请仍在审，全球非独占生产供货权不等于已发生出口供货。",
            "source_ids": [
              "S30"
            ],
            "website": "https://static.cninfo.com.cn/finalpage/2026-10-09/1225598013.PDF"
          },
          {
            "category": "电子注射装置",
            "series": [],
            "representative_products": [
              {
                "name": "赛增隐针电子笔",
                "website": null
              }
            ],
            "description": "赛增长效/短效隐针电子笔为重复使用实体给药装置，配合相应药物；电子化及记忆功能未据此扩写对外云API。",
            "source_ids": [
              "S08",
              "S25"
            ],
            "website": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/pediatric-medical-devices"
          },
          {
            "category": "儿童家庭数字训练软件",
            "series": [],
            "representative_products": [
              {
                "name": "金数稳",
                "website": null
              }
            ],
            "description": "金数稳为线上CBIT训练小程序，从北京儿童医院研发团队合作获得家庭训练方案；不虚构独立原生App或确定的医疗器械批准。",
            "source_ids": [
              "S09",
              "S22"
            ],
            "website": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/pediatric-neurology"
          },
          {
            "category": "历史儿童诊断与评估设备",
            "series": [],
            "representative_products": [
              {
                "name": "金赛龄",
                "website": null
              },
              {
                "name": "金赛明",
                "website": null
              },
              {
                "name": "杰文ACCUNIQ",
                "website": null
              },
              {
                "name": "金蓓源",
                "website": null
              }
            ],
            "description": "2024年报列金赛龄可移动X射线、金赛明生长/末梢血检测、ACCUNIQ体成分分析及金蓓源生长发育机器人；现行目录未完整续列，持续经营与各产品自主/代理归属待核。",
            "source_ids": [
              "S33"
            ],
            "website": "https://disc.static.szse.cn/download/disc/disk03/finalpage/2025-04-21/abc12f96-ff86-48bc-8027-c62deb6ce708.PDF"
          },
          {
            "category": "历史骨龄评估软件",
            "series": [],
            "representative_products": [
              {
                "name": "贝思龄",
                "website": null
              }
            ],
            "description": "2024年报列贝思龄AI大数据骨龄评估系统；最新对外软件交付形态、商业状态及是否可独立使用未充分确认。",
            "source_ids": [
              "S33"
            ],
            "website": "https://disc.static.szse.cn/download/disc/disk03/finalpage/2025-04-21/abc12f96-ff86-48bc-8027-c62deb6ce708.PDF"
          },
          {
            "category": "历史儿童辅助贴片",
            "series": [],
            "representative_products": [
              {
                "name": "金馨稳",
                "website": null
              }
            ],
            "description": "2024年报列金馨稳褪黑素贴片；不是已确认获批褪黑素颗粒，也不以该旧条目替代当前注册或销售证明。",
            "source_ids": [
              "S33"
            ],
            "website": "https://disc.static.szse.cn/download/disc/disk03/finalpage/2025-04-21/abc12f96-ff86-48bc-8027-c62deb6ce708.PDF"
          },
          {
            "category": "历史儿童止咳中成药",
            "series": [],
            "representative_products": [
              {
                "name": "金赛克",
                "website": null
              }
            ],
            "description": "2024年报列已推出的小儿黄金止咳颗粒金赛克；保留中成药经营范围，现行目录及2025报告未续列，当前推广销售状态待核，未混入华康全部中药目录。",
            "source_ids": [
              "S33"
            ],
            "website": "https://disc.static.szse.cn/download/disc/disk03/finalpage/2025-04-21/abc12f96-ff86-48bc-8027-c62deb6ce708.PDF"
          }
        ],
        "services": [
          {
            "name": "药物与技术地域许可",
            "description": "具体已成交为上海赛增向Yarrow交付GenSci098大中华区以外开发、生产和商业化独家权利及相关研发资料；2026上半年已确认首款，候选药尚在临床。官网另提供平台授权、合作开发及联合研究洽谈，但不据招募宣称每项已有付费成交。",
            "source_ids": [
              "S01",
              "S02",
              "S21",
              "S26"
            ],
            "website": "https://www.genscigroup.com/bd-cooperation"
          },
          {
            "name": "家庭CBIT训练方案在线服务",
            "description": "通过金数稳小程序提供家庭训练方案和管理，属真实在线内容/训练交付；未证实独立医生远程诊疗、实时一对一治疗或公开开发者API。",
            "source_ids": [
              "S22"
            ],
            "website": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/pediatric-neurology"
          },
          {
            "name": "院企数字建模与3D定制技术支持",
            "description": "2025年广元医院共建中心已启动，金赛提供外科数字建模、3D导航模板及康复技术支持；材料研发和更多中心为后续计划，未声称全部已完成或给出收费规模。",
            "source_ids": [
              "S32"
            ],
            "website": "https://www.genscigroup.com/about/news/express/211.html"
          }
        ]
      },
      {
        "name": "金派格 GenPEG",
        "description": "金赛全资子公司吉林省金派格药业的PEG原料及技术服务品牌，既内部供应也对外商业交付。",
        "source_ids": [
          "S13",
          "S14"
        ],
        "website": "https://www.genpeg.com/homeyb.html",
        "industries": [
          {
            "level1": "医药健康",
            "level2": "医药原料与定制技术"
          }
        ],
        "products": [
          {
            "category": "PEG及活性衍生物原料",
            "series": [],
            "representative_products": [
              {
                "name": "mPEG-pALD",
                "website": null
              },
              {
                "name": "4-arm PEG-SG",
                "website": null
              },
              {
                "name": "4-arm/8-arm PEG衍生物",
                "website": null
              }
            ],
            "description": "线性单/双官能化、多臂PEG及相应活性衍生物，端基和分子量作为系列；与已配制成的患者用药分开。",
            "source_ids": [
              "S14",
              "S18",
              "S19"
            ],
            "website": "https://www.genpeg.com/Products/4.html"
          },
          {
            "category": "核酸递送相关脂质及聚合物原料",
            "series": [],
            "representative_products": [
              {
                "name": "ALC-0315",
                "website": null
              },
              {
                "name": "ALC-0159",
                "website": null
              },
              {
                "name": "SM-102",
                "website": null
              }
            ],
            "description": "LNP目录有离子化脂质和PEG脂质等材料，包含ALC0315、ALC0159、SM102等；不将其写为已售整套自有mRNA疫苗或成品治疗药。",
            "source_ids": [
              "S17"
            ],
            "website": "https://www.genpeg.com/Products/5.html"
          }
        ],
        "services": [
          {
            "name": "PEG定制合成与分析",
            "description": "面向制药研发客户，在保密约定下提供文献检索、合成路线设计、目标PEG合成及分析，交付定制化合物；是独立技术服务，非普通售后。",
            "source_ids": [
              "S15"
            ],
            "website": "https://www.genpeg.com/about1_1/1.html"
          },
          {
            "name": "PEG化及下游技术支持",
            "description": "官网与金赛产业园页明确对外提供聚乙二醇化服务；服务页有与合成页复用内容，保留已证实PEG修饰技术交付，不杜撰细分专有流程、客户或全部药物合同生产。",
            "source_ids": [
              "S13",
              "S16"
            ],
            "website": "https://www.genpeg.com/about1_1/2.html"
          }
        ]
      },
      {
        "name": "FindCare",
        "description": "金赛健康旗下跨境营养品牌，以金赛官网实际品牌页为对象，合作代工厂不等于金赛自营海外设施。",
        "source_ids": [
          "S09",
          "S12"
        ],
        "website": "https://www.genscigroup.com/subsidiary-index",
        "industries": [
          {
            "level1": "消费品",
            "level2": "营养食品"
          }
        ],
        "products": [
          {
            "category": "赖氨酸复合营养食品",
            "series": [],
            "representative_products": [
              {
                "name": "赖氨酸成长粉",
                "website": null
              },
              {
                "name": "赖氨酸复合成长饮",
                "website": null
              },
              {
                "name": "赖氨酸成长胶囊",
                "website": null
              }
            ],
            "description": "实际有成长粉、复合饮品、成长胶囊等形态，作为同类复合营养商品系列，不当生长激素药或证明长高疗效。",
            "source_ids": [
              "S12"
            ],
            "website": "https://www.genscigroup.com/subsidiary-index"
          },
          {
            "category": "PS复合营养胶囊",
            "series": [],
            "representative_products": [
              {
                "name": "FindCare PS脑营养胶囊",
                "website": null
              }
            ],
            "description": "PS脑营养/益智胶囊为营养商品，保留与赖氨酸系列的配方定位差异，不复制宣传为经过医学证明的智力提升。",
            "source_ids": [
              "S09",
              "S12"
            ],
            "website": "https://www.genscigroup.com/subsidiary-index"
          }
        ],
        "services": []
      },
      {
        "name": "金蓓高",
        "description": "金赛下属食品业务的儿童营养品牌；蓓高贝、蓓全源、蓓畅宝、蓓护力、蓓育宁等保留系列名。",
        "source_ids": [
          "S01",
          "S09",
          "S10",
          "S24"
        ],
        "website": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/child-nutrition",
        "industries": [
          {
            "level1": "消费品",
            "level2": "营养食品"
          }
        ],
        "products": [
          {
            "category": "营养粉与复合饮品",
            "series": [],
            "representative_products": [],
            "description": "GABA乳清蛋白固体饮料、膳食纤维益生元饮品、柠檬酸钙胶原蛋白肽饮品、钙锌口服液及牛脾肽等风味饮料；食品与处方药/治疗方案分开。",
            "source_ids": [
              "S09",
              "S10",
              "S24"
            ],
            "website": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/child-nutrition"
          },
          {
            "category": "儿童乳粉",
            "series": [],
            "representative_products": [
              {
                "name": "儿童成长奶粉",
                "website": null
              }
            ],
            "description": "儿童成长奶粉属于乳粉食品，区别于普通固体饮料，也未统一称为特殊医学用途配方食品。",
            "source_ids": [
              "S10",
              "S24"
            ],
            "website": "https://www.genscigroup.com/commercial-products/others-products_5"
          },
          {
            "category": "营养糖果",
            "series": [],
            "representative_products": [],
            "description": "GABA夹心软糖等糖果形态，规格及口味作为系列，不按每种营养成分拆品牌。",
            "source_ids": [
              "S09"
            ],
            "website": "https://www.genscigroup.com/commercial-products/others-products_4"
          },
          {
            "category": "草本膏滋食品",
            "series": [],
            "representative_products": [],
            "description": "多联草本膏、鸡内金复合草本精粹膏等药食同源配方食品，未当获批中成药或据此宣称治疗疾病。",
            "source_ids": [
              "S10",
              "S24"
            ],
            "website": "https://www.genscigroup.com/commercial-products/others-products_5"
          }
        ],
        "services": []
      },
      {
        "name": "Neauvia（约定地区代理）",
        "description": "瑞士Matex合作医美品牌，金赛在约定地区开展注册/推广/分销等，非金赛自有全球商标与全部海外子公司。官网称香港澳门上市、内地临床注册中。",
        "source_ids": [
          "S06",
          "S07",
          "S23",
          "S33"
        ],
        "website": "https://www.genscigroup.com/business-cooperation/marketed-product/skin-lmmunity/pico-aesthetic-medicine",
        "industries": [
          {
            "level1": "医药健康",
            "level2": "代理医美材料及设备"
          }
        ],
        "products": [
          {
            "category": "注射型透明质酸填充及保湿材料",
            "series": [],
            "representative_products": [
              {
                "name": "Neauvia Stimulate",
                "website": null
              },
              {
                "name": "Neauvia Hydro Deluxe",
                "website": null
              },
              {
                "name": "Neauvia Intense",
                "website": null
              }
            ],
            "description": "Stimulate含CaHA复合填充、Hydro Deluxe及Intense等，作为医美注射材料商品系列；不照搬安全/美容效果宣传作医学结论。",
            "source_ids": [
              "S23",
              "S33"
            ],
            "website": "https://www.genscigroup.com/business-cooperation/marketed-product/skin-lmmunity/pico-aesthetic-medicine"
          },
          {
            "category": "医美能量设备",
            "series": [],
            "representative_products": [
              {
                "name": "Neauvia Zaffiro",
                "website": null
              },
              {
                "name": "Neauvia Sectum",
                "website": null
              },
              {
                "name": "Neauvia LaserME",
                "website": null
              }
            ],
            "description": "Zaffiro红外热疗、Sectum双极射频、LaserME激光设备；实际仪器与注射材料分开，地区批准及销售范围不由国际品牌足迹外推。",
            "source_ids": [
              "S07",
              "S23",
              "S33"
            ],
            "website": "https://www.genscigroup.com/commercial-products/others-products_2"
          }
        ],
        "services": []
      },
      {
        "name": "ALK脱敏产品（授权经营）",
        "description": "丹麦ALK为外部权利方，金赛在中国大陆取得约定产品独家代理/联合开发权益；安脱达、安刺保留商品名，不将ALK全球业务并入金赛。",
        "source_ids": [
          "S05",
          "S21",
          "S29"
        ],
        "website": "https://www.genscigroup.com/bd-cooperation",
        "industries": [
          {
            "level1": "医药健康",
            "level2": "授权过敏产品"
          }
        ],
        "products": [
          {
            "category": "变应原免疫治疗制剂",
            "series": [],
            "representative_products": [
              {
                "name": "安脱达（已经营）",
                "website": null
              },
              {
                "name": "GenSci171/ACARIZAX（中国临床）",
                "website": null
              }
            ],
            "description": "安脱达屋尘螨变应原制剂已有中国经营；GenSci171/ACARIZAX舌下片仅中国III期达终点，待上市批准，未把“安立闪商业化推进”宣传当已批上市。",
            "source_ids": [
              "S02",
              "S05",
              "S21",
              "S29"
            ],
            "website": "https://www.genscigroup.com/commercial-products/core-products"
          },
          {
            "category": "过敏诊断试剂",
            "series": [],
            "representative_products": [
              {
                "name": "安刺",
                "website": null
              }
            ],
            "description": "安刺螨变应原皮肤点刺试剂盒用于辅助诊断，与脱敏药不同交付。",
            "source_ids": [
              "S01",
              "S05",
              "S21"
            ],
            "website": "https://www.genscigroup.com/commercial-products/core-products"
          }
        ],
        "services": []
      },
      {
        "name": "固益素（历史营养产品线）",
        "description": "2024年报列示的营养商品品牌；现行完整目录未续列，持续销售及当前范围未充分确认，不断言停产。",
        "source_ids": [
          "S33"
        ],
        "website": null,
        "industries": [
          {
            "level1": "消费品",
            "level2": "营养食品"
          }
        ],
        "products": [
          {
            "category": "历史营养食品",
            "series": [],
            "representative_products": [],
            "description": "2024披露GABA粉饮、叶黄素酯软糖及钙铁锌运动营养复合饮品，当前经营状态待核。",
            "source_ids": [
              "S33"
            ],
            "website": "https://www.genscigroup.com"
          }
        ],
        "services": []
      },
      {
        "name": "赛必健（历史体重管理产品线）",
        "description": "2024年报明确列示的体重管理经营品牌；现行目录未续列，最新销售及服务持续状态待核。",
        "source_ids": [
          "S33"
        ],
        "website": null,
        "industries": [
          {
            "level1": "医药健康",
            "level2": "体重管理"
          }
        ],
        "products": [
          {
            "category": "历史体重管理食品",
            "series": [],
            "representative_products": [],
            "description": "胃内占容食品、运动营养食品、益生菌及玫瑰固体饮料/咖啡饮料等；不把旧食品名称等同正在申报的三类减重医疗器械。",
            "source_ids": [
              "S33"
            ],
            "website": "https://www.genscigroup.com"
          }
        ],
        "services": [
          {
            "name": "历史个性化体重管理方案",
            "description": "2024年报称面向不同肥胖人群提供个性化方案；现行目录未确认继续服务、收费或人员配置，作为历史范围保留。",
            "source_ids": [
              "S33"
            ],
            "website": "https://www.genscigroup.com"
          }
        ]
      },
      {
        "name": "赛优姿（历史足脊产品线）",
        "description": "2024年报列示的足脊评估干预品牌；2025医学3D合作说明相关技术，但未证实该品牌2026完整持续经营状态。",
        "source_ids": [
          "S32",
          "S33"
        ],
        "website": null,
        "industries": [
          {
            "level1": "医药健康",
            "level2": "足脊评估及康复"
          }
        ],
        "products": [
          {
            "category": "历史足脊评估治疗设备及干预用品",
            "series": [],
            "representative_products": [],
            "description": "2024年报列足脊健康筛查评估/治疗设备与干预改善产品；未取得最新具体型号和销售证明，不补造植入物或鞋垫材料。",
            "source_ids": [
              "S33"
            ],
            "website": "https://www.genscigroup.com"
          }
        ],
        "services": [
          {
            "name": "历史足脊康复及医学3D合作",
            "description": "旧年报列康复运动课程及医学3D打印中心合作；2025实际项目技术支持已在金赛主品牌列示，不重复当新付费合同或自营医院。",
            "source_ids": [
              "S32",
              "S33"
            ],
            "website": "https://www.genscigroup.com"
          }
        ]
      }
    ],
    "services": []
  },
  "global_presence": {
    "paragraphs": [
      {
        "text": "官网“40+药物惠及国家和地区”未明确排除中国，不据此填净境外国数。美国Yarrow有已实际收款的研发许可交付，可确认为美国B2B业务；GenSci098海外二期、其他FDA临床许可或技术参展不当作药品在当地上市销售。百克在印度等国的疫苗销售属于长春高新其他子公司，未转成金赛市场。",
        "source_ids": [
          "S02",
          "S04",
          "S26",
          "S28"
        ]
      },
      {
        "text": "中国现用设施包括长春生长激素产业园、国际医药产业园、敦化金派格以及上海科创/研发总部。当前官网全球布局明确旧金山和芝加哥研发中心、瑞士洛桑研发中心；泰国曼谷和新加坡标子公司，但未完整核实当前自用固定设施，未将法人标注直接计入设施。",
        "source_ids": [
          "S13",
          "S14",
          "S20"
        ]
      },
      {
        "text": "Neauvia由金赛经营的约定区域包括中国内地与港澳等，现行官网称香港澳门已上市、内地临床注册中，不能把Neauvia品牌本身的全球销售网络记为金赛覆盖。FindCare选择国际合作工厂及GMP/TGA认证，亦不等于金赛在澳洲自营工厂。",
        "source_ids": [
          "S12",
          "S23",
          "S33"
        ]
      },
      {
        "text": "上海创新中心历史奠基、现用总部及仍在建扩建阶段分别理解；广元医院共建医学3D打印中心为合作项目，不当自营医院。六洲没有充分证据的具体市场与设施保留缺失说明。",
        "source_ids": [
          "S04",
          "S20",
          "S32",
          "S34",
          "S35"
        ]
      }
    ],
    "market_regions": [
      {
        "region": "亚洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      },
      {
        "region": "欧洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      },
      {
        "region": "非洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      },
      {
        "region": "北美洲",
        "countries": [
          "美国"
        ],
        "source_ids": [
          "S02",
          "S26",
          "S28"
        ]
      },
      {
        "region": "南美洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      },
      {
        "region": "大洋洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      }
    ],
    "operating_regions": [
      {
        "region": "亚洲",
        "countries": [
          "中国"
        ],
        "source_ids": [
          "S13",
          "S14",
          "S20"
        ]
      },
      {
        "region": "欧洲",
        "countries": [
          "瑞士"
        ],
        "source_ids": [
          "S20"
        ]
      },
      {
        "region": "非洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      },
      {
        "region": "北美洲",
        "countries": [
          "美国"
        ],
        "source_ids": [
          "S20"
        ]
      },
      {
        "region": "南美洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      },
      {
        "region": "大洋洲",
        "countries": [
          "-"
        ],
        "source_ids": []
      }
    ]
  },
  "developments": {
    "window": {
      "start": "2025-11-10",
      "end": "2026-11-10",
      "max_items": 5
    },
    "items": [
      {
        "id": "E01",
        "title": "ALK合作尘螨舌下片中国III期达主要终点",
        "importance": "major",
        "display_date": "2026-10-22",
        "summary": "GenSci171/ACARIZAX在中国12—65岁伴或不伴哮喘尘螨过敏性鼻炎/鼻结膜炎参与者的III期达到主要终点，后续拟支持中国上市申请；尚未由该结果获得中国上市批准。",
        "status": "completed_per_company_statement",
        "source_ids": [
          "S29"
        ]
      },
      {
        "id": "E02",
        "title": "6个月亮丙瑞林进口制剂获中国注册批准",
        "importance": "major",
        "display_date": "2026-10-09",
        "summary": "金赛与逸达合作的甲磺酸亮丙瑞林注射液6M获准用于需要雄激素去势治疗的前列腺癌，属境外生产药品注册；乳腺癌申请仍在审。中国区开发销售及本土化/全球非独占供货权益不等于已实现全部供货。",
        "status": "completed_per_company_statement",
        "source_ids": [
          "S30"
        ]
      },
      {
        "id": "E03",
        "title": "儿童CPP曲普瑞林1月缓释制剂获批",
        "importance": "major",
        "display_date": "2026-06-26",
        "summary": "公司披露注射用醋酸曲普瑞林II获准用于体重20kg及以上儿童中枢性性早熟，属1个月缓释剂型；不混为短效曲普瑞林或6个月亮丙瑞林。",
        "status": "completed_per_company_statement",
        "source_ids": [
          "S31"
        ]
      },
      {
        "id": "E04",
        "title": "GenSci098首笔境外许可落地并推进实收及海外临床",
        "importance": "major",
        "display_date": "2025-12-15",
        "summary": "上海赛增与美国Yarrow宣布签署GenSci098大中华区以外独家许可：7000万美元不可退还首付款与5000万美元近期开发里程碑。中文披露另称至多13.65亿美元里程碑，英文称总交易值，未自行加总。7000万美元2026年1月到账并在上半年确认；截至7月披露海外二期首例及快速通道，仍未上市。",
        "status": "completed_per_company_statement",
        "source_ids": [
          "S01",
          "S02",
          "S26",
          "S27",
          "S28"
        ]
      }
    ]
  },
  "sources": [
    {
      "id": "S01",
      "title": "金赛药业｜长春高新2025年度报告中的金赛分项",
      "url": "https://disc.static.szse.cn/disc/disk03/finalpage/2026-04-22/e6c8c213-2bc6-409d-a2dd-069fdcc687e0.PDF",
      "type": "official_report",
      "accessed_on": "2026-11-11",
      "published_at": "2026-04-22"
    },
    {
      "id": "S02",
      "title": "金赛药业｜长春高新2026半年度报告中的金赛披露",
      "url": "https://disc.static.szse.cn/download/disc/disk03/finalpage/2026-08-21/08888dbf-dbd7-471d-87bf-f9a6fee4a7fa.PDF",
      "type": "official_report",
      "accessed_on": "2026-11-11",
      "published_at": "2026-08-21"
    },
    {
      "id": "S03",
      "title": "金赛药业｜长春高新2026第三季度报告",
      "url": "https://static.cninfo.com.cn/finalpage/2026-10-30/1225643846.PDF",
      "type": "official_report",
      "accessed_on": "2026-11-11",
      "published_at": "2026-10-30"
    },
    {
      "id": "S04",
      "title": "金赛药业｜金赛现行公司概况及沿革",
      "url": "https://www.genscigroup.com/about",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S05",
      "title": "金赛药业｜核心上市产品目录",
      "url": "https://www.genscigroup.com/commercial-products/core-products",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S06",
      "title": "金赛药业｜其他产品第1页",
      "url": "https://www.genscigroup.com/commercial-products/others-products",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S07",
      "title": "金赛药业｜其他产品第2页",
      "url": "https://www.genscigroup.com/commercial-products/others-products_2",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S08",
      "title": "金赛药业｜其他产品第3页",
      "url": "https://www.genscigroup.com/commercial-products/others-products_3",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S09",
      "title": "金赛药业｜其他产品第4页",
      "url": "https://www.genscigroup.com/commercial-products/others-products_4",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S10",
      "title": "金赛药业｜其他产品第5页",
      "url": "https://www.genscigroup.com/commercial-products/others-products_5",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S11",
      "title": "金赛药业｜其他产品第6页",
      "url": "https://www.genscigroup.com/commercial-products/others-products_6",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S12",
      "title": "金赛药业｜FindCare品牌与产品",
      "url": "https://www.genscigroup.com/subsidiary-index",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S13",
      "title": "金赛药业｜金赛生产运营及产业园",
      "url": "https://www.genscigroup.com/about/bases",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S14",
      "title": "金赛药业｜金派格公司及商品首页",
      "url": "https://www.genpeg.com/homeyb.html",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S15",
      "title": "金赛药业｜金派格定制合成",
      "url": "https://www.genpeg.com/about1_1/1.html",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S16",
      "title": "金赛药业｜金派格聚乙二醇化服务",
      "url": "https://www.genpeg.com/about1_1/2.html",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S17",
      "title": "金赛药业｜金派格LNP递送原料目录",
      "url": "https://www.genpeg.com/Products/5.html",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S18",
      "title": "金赛药业｜金派格线性PEG衍生物",
      "url": "https://www.genpeg.com/Products/4.html",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S19",
      "title": "金赛药业｜金派格多臂PEG衍生物",
      "url": "https://www.genpeg.com/Products/2.html",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S20",
      "title": "金赛药业｜金赛总部及全球布局",
      "url": "https://www.genscigroup.com/about/contact",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S21",
      "title": "金赛药业｜金赛创新合作与授权案例",
      "url": "https://www.genscigroup.com/bd-cooperation",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S22",
      "title": "金赛药业｜儿童神经上市产品及金数稳说明",
      "url": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/pediatric-neurology",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S23",
      "title": "金赛药业｜医美皮科具体产品",
      "url": "https://www.genscigroup.com/business-cooperation/marketed-product/skin-lmmunity/pico-aesthetic-medicine",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S24",
      "title": "金赛药业｜儿童营养具体商品",
      "url": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/child-nutrition",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S25",
      "title": "金赛药业｜儿童药械具体商品",
      "url": "https://www.genscigroup.com/business-cooperation/marketed-product/listed-products/pediatric-medical-devices",
      "type": "official",
      "accessed_on": "2026-11-11"
    },
    {
      "id": "S26",
      "title": "金赛药业｜GenSci098授权中文条款",
      "url": "https://www.genscigroup.com/about/news/express/300.html",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2025-12-19"
    },
    {
      "id": "S27",
      "title": "金赛药业｜GenSci098授权英文公司公告",
      "url": "https://www.genscigroup.com/en/news/media/183",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2025-12-16"
    },
    {
      "id": "S28",
      "title": "金赛药业｜海外GenSci098二期首例与FDA快速通道",
      "url": "https://www.genscigroup.com/about/news/express/378.html",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2026-07-30"
    },
    {
      "id": "S29",
      "title": "金赛药业｜GenSci171尘螨舌下片三期达终点",
      "url": "https://www.genscigroup.com/about/news/express/396.html",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2026-10-22"
    },
    {
      "id": "S30",
      "title": "金赛药业｜6M亮丙瑞林药品注册证书公告",
      "url": "https://static.cninfo.com.cn/finalpage/2026-10-09/1225598013.PDF",
      "type": "official_report",
      "accessed_on": "2026-11-11",
      "published_at": "2026-10-09"
    },
    {
      "id": "S31",
      "title": "金赛药业｜儿童CPP曲普瑞林缓释制剂获批",
      "url": "https://www.genscigroup.com/about/news/express/367.html",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2026-06-26"
    },
    {
      "id": "S32",
      "title": "金赛药业｜院企医学3D打印中心实际启动",
      "url": "https://www.genscigroup.com/about/news/express/211.html",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2025-06-23"
    },
    {
      "id": "S33",
      "title": "金赛药业｜2024年报历史详细商品及服务范围",
      "url": "https://disc.static.szse.cn/download/disc/disk03/finalpage/2025-04-21/abc12f96-ff86-48bc-8027-c62deb6ce708.PDF",
      "type": "official_report",
      "accessed_on": "2026-11-11",
      "published_at": "2025-04-21"
    },
    {
      "id": "S34",
      "title": "金赛药业｜Partex AI合作与自有研发平台说明",
      "url": "https://www.genscigroup.com/about/news/express/302.html",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2025-12-23"
    },
    {
      "id": "S35",
      "title": "金赛药业｜2026研发日的关键进展",
      "url": "https://www.genscigroup.com/about/news/express/400",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2026-11-03"
    },
    {
      "id": "S36",
      "title": "金赛药业｜2021官网旧创立口径",
      "url": "https://www.genscigroup.com/about/news/express/60",
      "type": "official_news",
      "accessed_on": "2026-11-11",
      "published_at": "2021-06-08"
    },
    {
      "id": "S37",
      "title": "金赛药业｜澎湃：长春高新三季报披露时间与金赛分项",
      "url": "https://www.thepaper.cn/newsDetail_forward_34367835",
      "type": "media",
      "accessed_on": "2026-11-11",
      "published_at": "2026-10-30"
    },
    {
      "id": "S38",
      "title": "金赛药业｜益普舒口腔凝胶官方说明书",
      "url": "https://www.genscigroup.com/Public/Uploads/uploadfile/files/20260525/kouqiangningjiaoshuomingshu.pdf",
      "type": "official",
      "accessed_on": "2026-11-11"
    }
  ],
  "report_template": "core-v4"
}
